French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

Recurrent urinary tract infections could signal kidney cancer. This disease often progresses without clear symptoms. Early ...

Benign Prostatic Hyperplasia (BPH) commonly affects men over 50, causing urinary issues due to an enlarged prostate. Age, ...

EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at ...

(Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive review of the ...

Several medical conditions can mimic prostate cancer, causing many of the same symptoms, including painful ejaculation and ...

In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...

AIxMed Inc., a leader in computational cytology and AI-powered diagnostics, and Biopticka Laboratoř s.r.o., the Czech ...

After finding the charity Prost8, founded by Paul Sayer, Jason got a referral letter for treatment from his GP, which he said ...

Jason Yeo was shocked to discover he had prostate cancer in April 2024 as he was healthy, sporty and ‘symptomless’.

Lisa Gorman has stepped into the role of consultant in order to help bring the brand vision of Swimmable to life.